LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.325
+0.015 (1.15%)
At close: Jun 23, 2025, 4:00 PM
1.360
+0.035 (2.64%)
After-hours: Jun 23, 2025, 4:00 PM EDT
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $34.85 million as of June 23, 2025. Its market cap has decreased by -43.10% in one year.
Market Cap
34.85M
Enterprise Value
-31.39M
1-Year Change
-43.10%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has decreased from $380.28M to $34.85M, a decrease of -90.83%. That is a compound annual growth rate of -43.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 34.46M | 37.78% |
| Dec 31, 2024 | 25.01M | -39.79% |
| Dec 29, 2023 | 41.54M | -54.86% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | -62.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.83B |
| Johnson & Johnson | 364.09B |
| AbbVie | 324.59B |
| Novo Nordisk | 309.67B |
| UnitedHealth Group | 272.76B |
| Abbott Laboratories | 231.85B |
| Novartis AG | 229.25B |
| AstraZeneca | 218.15B |